WVU Medicine has agreed to pay $4.17 million to the federal government to settle civil allegations involving “significant losses of controlled substances” from medical facilities over seven years, according to the U.S. Attorney’s office in Wheeling.

The U.S. Attorney’s office for the Northern District of West Virginia alleged that West Virginia University Health System, which does business as WVU Medicine, had failed to notify the Drug Enforcement Administration of thefts or other losses of narcotics at various medical facilities between 2017 and 2024. Other violations include failures to keep accurate and current drug inventory records.

“When a health care system controls large quantities of addictive medications, strict compliance with the Controlled Substance Act is necessary to protect the public,” First Assistant U.S. Attorney Christopher J. Prezioso said in a prepared release.

In addition to the financial settlement, WVU Medicine agreed to a three-year agreement with the DEA that imposes additional oversight to prevent the diversion of narcotics, requires rapid reporting of drug thefts or losses and the installation of hundreds of security cameras at controlled substance storage sites. The probe was conducted by U.S. Attorney’s offices in northern and southern districts of West Virginia and the settlement was announced July 13.

Advertise with us

In a prepared statement Wednesday, a WVU Medicine spokesperson said the agreement did not include an admission of liability for the allegations and patient care was not compromised. Even before the DEA investigation, the health system had invested millions of dollars in additional personnel, advanced diversion technology and expanded security measures, the spokesperson said.

“We are pleased to have resolved this matter and remain focused on providing the highest quality care to the patients and communities we serve,” the spokesperson said.

Among the incidents documented by the DEA — but not reported to the government as required — was “ample evidence” of narcotic diversion following an internal investigation in 2017; the 2021 admission by a medical provider to diverting powerful opioid pain relievers for about five years; and the admission by a nurse in 2022 of having stolen controlled substances. The DEA discovered instances of WVU Medicine staff “placing controlled substances in the pockets of their clothing or taking controlled substances to their homes,” according to the settlement agreement.

WVU Medicine, a fast-growing healthcare system based in Morgantown, is preparing to merge with Independence Health System, which operates five hospitals in Westmoreland, Butler and Clarion counties. The deal is expected to close by October, which means WVU Medicine will join Pittsburgh-based healthcare giants Allegheny Health Network and UPMC in serving Western Pennsylvania.

WVU Medicine operates 25 hospitals in West Virginia, Pennsylvania, Ohio and Maryland. In April, WVU Medicine announced a tentative affiliation agreement with the 26-bed Fulton County Medical Center, a critical access hospital in Fulton County, Eastern Pennsylvania.